Shogo Kotsuka
Direttore/Membro del Consiglio presso Biomedica Solution KK
Posizioni attive di Shogo Kotsuka
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Biomedica Solution KK
 Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Direttore/Membro del Consiglio | 01/02/2014 | - |
Storia della carriera di Shogo Kotsuka
Precedenti posizioni note di Shogo Kotsuka
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Titan, Inc. (Japan)
 Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - | - |
| TELLA, INC. | Direttore/Membro del Consiglio | 01/08/2010 | - |
| Direttore Finanziario/CFO | 01/03/2017 | - | |
| Contatto Relazioni con gli Investitori | 01/08/2010 | - |
Statistiche
Distribuzione geografica
| Giappone | 4 |
Posizioni
| Director/Board Member | 3 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Settori
| Health Technology | 3 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Titan, Inc. (Japan)
Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
Biomedica Solution KK
Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Health Technology |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Shogo Kotsuka
- Esperienza
